|
業務類別
|
Biotechnology |
|
業務概覽
|
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services. |
| 公司地址
| 10770 Wateridge Circle, Suite 200, San Diego, CA, USA, 92121 |
| 電話號碼
| +1 858 546-0004 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.maravai.com |
| 員工數量
| 570 |
| Ms. Christine Dolan |
Executive Vice President and General Manager, Cygnus Technologies |
-- |
18/04/2025 |
| Mr. Bernd Brust |
Director and Chief Executive Officer |
-- |
26/02/2026 |
| Mr. Kurt Oreshack |
General Counsel and Secretary |
-- |
18/04/2025 |
| Mr. Rajesh J. Asarpota |
Chief Financial Officer and Principal Accounting Officer |
-- |
26/02/2026 |
|
|
| Mr. Gregory T. Lucier |
Independent Director |
26/02/2026 |
| Dr. John A. DeFord, PhD |
Independent Director |
26/02/2026 |
| Mr. Bernd Brust |
Director and Chief Executive Officer |
26/02/2026 |
| Mr. Sean L. Cunningham |
Director |
26/02/2026 |
| Mr. Constantine S. Mihas |
Director |
26/02/2026 |
| Ms. Susannah Gray, M.B.A. |
Independent Director |
26/02/2026 |
| Mr. Luke Marker |
Director |
26/02/2026 |
| Mr. Robert Andrew Eckert |
Chairman of the Board |
26/02/2026 |
|
|
|
|
